| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | RNA splicing | 3.43e-06 | 502 | 11 | 5 | GO:0008380 | |
| GeneOntologyBiologicalProcess | mRNA processing | 5.40e-06 | 551 | 11 | 5 | GO:0006397 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 6.34e-05 | 917 | 11 | 5 | GO:0016071 | |
| GeneOntologyBiologicalProcess | RNA processing | 6.44e-04 | 1500 | 11 | 5 | GO:0006396 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 7.71e-04 | 358 | 11 | 3 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 7.71e-04 | 358 | 11 | 3 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 7.97e-04 | 362 | 11 | 3 | GO:0000375 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.67e-04 | 215 | 11 | 3 | GO:0005681 | |
| GeneOntologyCellularComponent | precatalytic spliceosome | 3.55e-04 | 54 | 11 | 2 | GO:0071011 | |
| GeneOntologyCellularComponent | nuclear speck | 1.27e-03 | 431 | 11 | 3 | GO:0016607 | |
| Pathway | KEGG_SPLICEOSOME | 3.87e-05 | 127 | 8 | 3 | M2044 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.52e-04 | 201 | 8 | 3 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.78e-04 | 212 | 8 | 3 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 3.91e-04 | 277 | 8 | 3 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 4.16e-04 | 283 | 8 | 3 | M13087 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 3.87e-03 | 612 | 8 | 3 | MM15547 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 6.22e-03 | 724 | 8 | 3 | M16843 | |
| Pubmed | 8.40e-07 | 251 | 11 | 4 | 31076518 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.03e-06 | 1294 | 11 | 6 | 30804502 | |
| Pubmed | 1.68e-06 | 731 | 11 | 5 | 29298432 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 6.19e-06 | 954 | 11 | 5 | 36373674 | |
| Pubmed | 8.33e-06 | 1014 | 11 | 5 | 32416067 | ||
| Pubmed | 1.02e-05 | 472 | 11 | 4 | 38943005 | ||
| Pubmed | 1.88e-05 | 551 | 11 | 4 | 34728620 | ||
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 2.86e-05 | 197 | 11 | 3 | 22365833 | |
| Pubmed | 3.66e-05 | 653 | 11 | 4 | 22586326 | ||
| Pubmed | 5.15e-05 | 713 | 11 | 4 | 29802200 | ||
| Pubmed | 5.45e-05 | 1497 | 11 | 5 | 31527615 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.72e-04 | 361 | 11 | 3 | 26167880 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.83e-04 | 989 | 11 | 4 | 36424410 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.58e-04 | 1082 | 11 | 4 | 38697112 | |
| Pubmed | 2.60e-04 | 1084 | 11 | 4 | 11544199 | ||
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | 2.67e-04 | 419 | 11 | 3 | 28700943 | |
| Pubmed | 2.78e-04 | 1103 | 11 | 4 | 34189442 | ||
| Pubmed | 3.10e-04 | 441 | 11 | 3 | 31239290 | ||
| Interaction | DDX23 interactions | 7.39e-08 | 480 | 11 | 6 | int:DDX23 | |
| Interaction | DHX40 interactions | 1.20e-07 | 249 | 11 | 5 | int:DHX40 | |
| Interaction | SAP18 interactions | 3.29e-07 | 305 | 11 | 5 | int:SAP18 | |
| Interaction | TTC14 interactions | 3.93e-07 | 28 | 11 | 3 | int:TTC14 | |
| Interaction | UQCR11 interactions | 2.79e-06 | 53 | 11 | 3 | int:UQCR11 | |
| Interaction | IFI27L1 interactions | 5.19e-06 | 65 | 11 | 3 | int:IFI27L1 | |
| Interaction | TERF2IP interactions | 6.10e-06 | 552 | 11 | 5 | int:TERF2IP | |
| Interaction | SNRNP40 interactions | 1.22e-05 | 637 | 11 | 5 | int:SNRNP40 | |
| Interaction | DHX8 interactions | 1.32e-05 | 292 | 11 | 4 | int:DHX8 | |
| Interaction | PEA15 interactions | 1.38e-05 | 90 | 11 | 3 | int:PEA15 | |
| Interaction | EZH1 interactions | 1.48e-05 | 92 | 11 | 3 | int:EZH1 | |
| Interaction | SSRP1 interactions | 1.74e-05 | 685 | 11 | 5 | int:SSRP1 | |
| Interaction | ANKRD50 interactions | 2.39e-05 | 108 | 11 | 3 | int:ANKRD50 | |
| Interaction | MYCN interactions | 3.39e-05 | 1373 | 11 | 6 | int:MYCN | |
| Interaction | ANAPC15 interactions | 3.98e-05 | 128 | 11 | 3 | int:ANAPC15 | |
| Interaction | ZC3H18 interactions | 5.72e-05 | 877 | 11 | 5 | int:ZC3H18 | |
| Interaction | TFIP11 interactions | 5.83e-05 | 427 | 11 | 4 | int:TFIP11 | |
| Interaction | NIFK interactions | 6.04e-05 | 431 | 11 | 4 | int:NIFK | |
| Interaction | MALL interactions | 6.38e-05 | 150 | 11 | 3 | int:MALL | |
| Interaction | SNRPC interactions | 6.55e-05 | 440 | 11 | 4 | int:SNRPC | |
| Interaction | TCEAL7 interactions | 7.43e-05 | 24 | 11 | 2 | int:TCEAL7 | |
| Interaction | RAD18 interactions | 7.59e-05 | 457 | 11 | 4 | int:RAD18 | |
| Interaction | WBP11 interactions | 7.73e-05 | 160 | 11 | 3 | int:WBP11 | |
| Interaction | SNRPA interactions | 9.33e-05 | 482 | 11 | 4 | int:SNRPA | |
| Interaction | SMC5 interactions | 1.07e-04 | 1000 | 11 | 5 | int:SMC5 | |
| Interaction | SNRPB interactions | 1.22e-04 | 517 | 11 | 4 | int:SNRPB | |
| Interaction | LSM2 interactions | 1.31e-04 | 191 | 11 | 3 | int:LSM2 | |
| Interaction | SRSF11 interactions | 1.57e-04 | 203 | 11 | 3 | int:SRSF11 | |
| Interaction | IK interactions | 1.85e-04 | 215 | 11 | 3 | int:IK | |
| Interaction | CLK1 interactions | 1.96e-04 | 219 | 11 | 3 | int:CLK1 | |
| Interaction | TMSB4Y interactions | 1.99e-04 | 39 | 11 | 2 | int:TMSB4Y | |
| Interaction | NUP43 interactions | 2.54e-04 | 625 | 11 | 4 | int:NUP43 | |
| Interaction | FRA10AC1 interactions | 3.01e-04 | 48 | 11 | 2 | int:FRA10AC1 | |
| Interaction | BMI1 interactions | 3.11e-04 | 659 | 11 | 4 | int:BMI1 | |
| Interaction | GAGE5 interactions | 3.54e-04 | 52 | 11 | 2 | int:GAGE5 | |
| Interaction | DPM2 interactions | 3.82e-04 | 54 | 11 | 2 | int:DPM2 | |
| Interaction | SAA1 interactions | 3.82e-04 | 54 | 11 | 2 | int:SAA1 | |
| Interaction | IFI6 interactions | 3.82e-04 | 54 | 11 | 2 | int:IFI6 | |
| Interaction | TOP1 interactions | 3.83e-04 | 696 | 11 | 4 | int:TOP1 | |
| Interaction | SIRT7 interactions | 4.94e-04 | 744 | 11 | 4 | int:SIRT7 | |
| Interaction | CIT interactions | 6.13e-04 | 1450 | 11 | 5 | int:CIT | |
| Interaction | TXNL4A interactions | 7.75e-04 | 77 | 11 | 2 | int:TXNL4A | |
| Interaction | LSM5 interactions | 7.95e-04 | 78 | 11 | 2 | int:LSM5 | |
| Interaction | PSENEN interactions | 8.57e-04 | 81 | 11 | 2 | int:PSENEN | |
| Interaction | PPIA interactions | 9.64e-04 | 888 | 11 | 4 | int:PPIA | |
| Interaction | SNRPF interactions | 1.02e-03 | 385 | 11 | 3 | int:SNRPF | |
| Interaction | OBSL1 interactions | 1.02e-03 | 902 | 11 | 4 | int:OBSL1 | |
| Interaction | GNL2 interactions | 1.03e-03 | 386 | 11 | 3 | int:GNL2 | |
| Interaction | CERK interactions | 1.08e-03 | 91 | 11 | 2 | int:CERK | |
| Interaction | PRMT1 interactions | 1.14e-03 | 929 | 11 | 4 | int:PRMT1 | |
| Interaction | LINC02910 interactions | 1.18e-03 | 95 | 11 | 2 | int:LINC02910 | |
| Interaction | SUPT5H interactions | 1.20e-03 | 408 | 11 | 3 | int:SUPT5H | |
| Interaction | SNRNP70 interactions | 1.41e-03 | 984 | 11 | 4 | int:SNRNP70 | |
| Interaction | HECTD1 interactions | 1.41e-03 | 984 | 11 | 4 | int:HECTD1 | |
| Interaction | SUPT16H interactions | 1.52e-03 | 442 | 11 | 3 | int:SUPT16H | |
| Interaction | ZNF330 interactions | 1.56e-03 | 446 | 11 | 3 | int:ZNF330 | |
| Interaction | TSSC4 interactions | 1.60e-03 | 111 | 11 | 2 | int:TSSC4 | |
| Interaction | RSRC1 interactions | 1.63e-03 | 112 | 11 | 2 | int:RSRC1 | |
| Interaction | RBM39 interactions | 1.75e-03 | 1042 | 11 | 4 | int:RBM39 | |
| Interaction | PHF3 interactions | 1.81e-03 | 118 | 11 | 2 | int:PHF3 | |
| Interaction | PAXBP1 interactions | 1.90e-03 | 121 | 11 | 2 | int:PAXBP1 | |
| Interaction | ARID3A interactions | 1.93e-03 | 122 | 11 | 2 | int:ARID3A | |
| Interaction | POLR1G interactions | 2.03e-03 | 489 | 11 | 3 | int:POLR1G | |
| Interaction | H2AJ interactions | 2.09e-03 | 127 | 11 | 2 | int:H2AJ | |
| Interaction | SRSF6 interactions | 2.20e-03 | 503 | 11 | 3 | int:SRSF6 | |
| Interaction | NKAP interactions | 2.25e-03 | 132 | 11 | 2 | int:NKAP | |
| Interaction | DNAJC17 interactions | 2.32e-03 | 134 | 11 | 2 | int:DNAJC17 | |
| Interaction | SCO2 interactions | 2.32e-03 | 134 | 11 | 2 | int:SCO2 | |
| Interaction | CPSF6 interactions | 2.49e-03 | 526 | 11 | 3 | int:CPSF6 | |
| Interaction | ESS2 interactions | 2.53e-03 | 140 | 11 | 2 | int:ESS2 | |
| Interaction | PRNP interactions | 2.58e-03 | 1158 | 11 | 4 | int:PRNP | |
| Interaction | SUGP1 interactions | 2.64e-03 | 143 | 11 | 2 | int:SUGP1 | |
| Interaction | CACTIN interactions | 2.67e-03 | 144 | 11 | 2 | int:CACTIN | |
| Interaction | FBXO22 interactions | 2.69e-03 | 540 | 11 | 3 | int:FBXO22 | |
| Interaction | COIL interactions | 2.86e-03 | 552 | 11 | 3 | int:COIL | |
| Interaction | SLTM interactions | 3.13e-03 | 156 | 11 | 2 | int:SLTM | |
| Interaction | SLU7 interactions | 3.13e-03 | 156 | 11 | 2 | int:SLU7 | |
| Interaction | ZC3H13 interactions | 3.21e-03 | 158 | 11 | 2 | int:ZC3H13 | |
| Interaction | ANKRD11 interactions | 3.25e-03 | 159 | 11 | 2 | int:ANKRD11 | |
| Interaction | NKAPD1 interactions | 3.33e-03 | 161 | 11 | 2 | int:NKAPD1 | |
| Interaction | CEBPA interactions | 3.37e-03 | 1245 | 11 | 4 | int:CEBPA | |
| Interaction | YWHAG interactions | 3.40e-03 | 1248 | 11 | 4 | int:YWHAG | |
| Interaction | APEX1 interactions | 3.63e-03 | 1271 | 11 | 4 | int:APEX1 | |
| Interaction | DHX38 interactions | 3.70e-03 | 170 | 11 | 2 | int:DHX38 | |
| Interaction | MECP2 interactions | 3.80e-03 | 1287 | 11 | 4 | int:MECP2 | |
| Interaction | ARGLU1 interactions | 3.96e-03 | 176 | 11 | 2 | int:ARGLU1 | |
| Interaction | C9orf78 interactions | 3.97e-03 | 620 | 11 | 3 | int:C9orf78 | |
| Interaction | LSM4 interactions | 4.05e-03 | 178 | 11 | 2 | int:LSM4 | |
| Interaction | XAB2 interactions | 4.41e-03 | 186 | 11 | 2 | int:XAB2 | |
| Interaction | U2AF2 interactions | 4.56e-03 | 651 | 11 | 3 | int:U2AF2 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 2.13e-05 | 429 | 11 | 4 | M29 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | 8.52e-05 | 612 | 11 | 4 | MM3804 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.71e-06 | 249 | 11 | 4 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.67e-06 | 259 | 11 | 4 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.46e-06 | 275 | 11 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 2.47e-04 | 1257 | 11 | 5 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.35e-04 | 277 | 11 | 3 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.50e-04 | 281 | 11 | 3 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.61e-04 | 284 | 11 | 3 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 4.95e-04 | 1459 | 11 | 5 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 5.26e-04 | 797 | 11 | 4 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 5.36e-04 | 801 | 11 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 5.49e-04 | 806 | 11 | 4 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | e9.5_FaceMesenchy_top-relative-expression-ranked_500 | 7.44e-04 | 364 | 11 | 3 | Facebase_ST1_e9.5_FaceMesenchy_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.22e-03 | 532 | 11 | 3 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 2.61e-03 | 150 | 11 | 2 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.62e-03 | 564 | 11 | 3 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 8.25e-06 | 168 | 11 | 3 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 184 | 11 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.29e-05 | 195 | 11 | 3 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.31e-05 | 196 | 11 | 3 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.35e-05 | 198 | 11 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.37e-05 | 199 | 11 | 3 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.37e-05 | 199 | 11 | 3 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.37e-05 | 199 | 11 | 3 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.37e-05 | 199 | 11 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.83e-04 | 135 | 11 | 2 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 5.04e-04 | 138 | 11 | 2 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.19e-04 | 165 | 11 | 2 | 5e7ee76f3dcddbd1b560bacd043f9001b0c18b5f | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-04 | 173 | 11 | 2 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-04 | 178 | 11 | 2 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.36e-04 | 178 | 11 | 2 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-04 | 188 | 11 | 2 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-04 | 191 | 11 | 2 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-04 | 191 | 11 | 2 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-04 | 191 | 11 | 2 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Control-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.62e-04 | 191 | 11 | 2 | 33fce8e086601e636e8c6ef2ab58fcfdd52af369 | |
| ToppCell | moderate-Lymphoid-Treg|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.72e-04 | 192 | 11 | 2 | e370ff5aaff7b7042ba9aaf93de43aa563b8b9f9 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 9.72e-04 | 192 | 11 | 2 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-Treg|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.72e-04 | 192 | 11 | 2 | 48d557071bad80edd3ec6e5ad8dcd97037da9553 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-04 | 194 | 11 | 2 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 9.92e-04 | 194 | 11 | 2 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.00e-03 | 195 | 11 | 2 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.02e-03 | 197 | 11 | 2 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.02e-03 | 197 | 11 | 2 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.02e-03 | 197 | 11 | 2 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-03 | 197 | 11 | 2 | 06e17c9ad53463eee1007280b3f3e8b0cf446cdc | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.03e-03 | 198 | 11 | 2 | 3c3a5d2555f6af4aa33f9ea778808315d0e39d86 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-03 | 198 | 11 | 2 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.03e-03 | 198 | 11 | 2 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.04e-03 | 199 | 11 | 2 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.04e-03 | 199 | 11 | 2 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.04e-03 | 199 | 11 | 2 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.04e-03 | 199 | 11 | 2 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.04e-03 | 199 | 11 | 2 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.04e-03 | 199 | 11 | 2 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.05e-03 | 200 | 11 | 2 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.05e-03 | 200 | 11 | 2 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.05e-03 | 200 | 11 | 2 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.05e-03 | 200 | 11 | 2 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.18e-04 | 49 | 9 | 2 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of SP3 | 1.86e-03 | 79 | 9 | 2 | MORF_SP3 | |
| Computational | Genes in the cancer module 204. | 2.20e-03 | 86 | 9 | 2 | MODULE_204 | |
| Disease | Awakening Epilepsy | 3.38e-04 | 82 | 10 | 2 | C0751111 | |
| Disease | Epilepsy, Cryptogenic | 3.38e-04 | 82 | 10 | 2 | C0086237 | |
| Disease | Aura | 3.38e-04 | 82 | 10 | 2 | C0236018 | |
| Disease | Epilepsy | 5.97e-04 | 109 | 10 | 2 | C0014544 | |
| Disease | Intellectual Disability | 9.51e-03 | 447 | 10 | 2 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKEEGREAYASDRHR | 1151 | Q6UB99 | |
| NKKDRDRDKDGHRRD | 86 | Q9BUQ8 | |
| DKSDRDRERGYDKVD | 136 | O60828 | |
| DRERGYDKVDRERER | 141 | O60828 | |
| DRERDRDRGYDKADR | 156 | O60828 | |
| RDRGYDKADREEGKE | 161 | O60828 | |
| YRRIDDDKGRTHELE | 101 | Q93100 | |
| RDRDYDKERGNEREK | 366 | Q5VTL8 | |
| DKDDRRHRDDKRDSK | 406 | Q5VTL8 | |
| KHRKRDRERDSGLED | 71 | Q6U841 | |
| REGEKDRDRYHKDRD | 2016 | Q92576 | |
| RFEKDIEGRKEHYRR | 646 | Q96N46 | |
| DREREEEKKRHSYFE | 371 | Q13123 | |
| GRDDFRKELERHARD | 286 | Q7L8A9 | |
| DYRDREGRDTHRKED | 506 | Q5T200 |